FDA Accelerated Programs in Drug Development

• February 13, 2025

PMDA Phase1 Waiver Guidelines for Japanese Participation in Global MRCTs

• February 7, 2025

Leadership and Policy Shifts in U.S. Healthcare: Potential Impacts on the Biopharma Industry

• January 31, 2025

US Agent for FDA Regulated Product Applications

• January 23, 2025